3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
3
Prostatic Neoplasms
2
Weight Loss
1
Urinary Bladder Neoplasms
1
Sleep Apnea Syndromes
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lung Neoplasms
1
Hypertension
1
Hyperlipidemias
1
Gastroesophageal Reflux
1
Eczema
1
Disease
1
Digestive System Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Dermatitis, Atopic
1
Collagen Diseases
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
5
pembrolizumab
2
fluciclovine F-18
2
Surveys and Questionnaires
2
Preoperative Exercise
2
Magnetic Resonance Imaging
2
Exercise
2
Cryosurgery
2
Bevacizumab
2
tislelizumab
1
neratinib
1
imetelstat
1
daratumumab
1
atezolizumab
1
abiraterone
1
Waiting Lists
1
Videotape Recording
1
Urine Specimen Collection
1
Transcutaneous Electric Nerve Stimulation
1
Tomography, X-Ray Computed
1
Thoracic Surgical Procedures
1
TIC10 compound
1
Sulfonylurea Compounds
1
Standard of Care
1
Specimen Handling
1
Sodium-Glucose Transporter 2 Inhibitors
1
Serologic Tests
1
Sequence Analysis, RNA
1
S-Adenosylmethionine
1
Referral and Consultation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Urine Specimen Collection
×
1 year
×
Clear all
NCT05151341
2025-07-24
URODX-FGFR3
Institut de Cancérologie de Lorraine
Phase NA
Completed
190 enrolled